The Home of the Life Sciences Industry

Explore Latest News

Smith Collection/Gado/Getty Images

Merck Snaps Up Autoimmune-Focused Pandion in Massive $1.85 Billion Deal

Merck said the acquisition adds a pipeline of drug candidates that target a broad range of autoimmune diseases.
Fabrice Chouraqui, CEO of Cellarity

Cellarity Takes in $123 Million to Drive Cell-Centric Drug Discovery Toward Clinic

The company uses computational modeling of cell behavior to treat disease, instead of going after a molecular target, redefining drug discovery through its cell-centric approach. 

Get personalized job alerts

Create a job alert and receive custom job recommendations straight to your inbox.


Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.

Post Jobs Now